{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:51:22Z","timestamp":1794408682285,"version":"4.9.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deanship of Scientific Research, Umm Al-Qura University","award":["19-MED-1-01-0033"],"award-info":[{"award-number":["19-MED-1-01-0033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This review discusses the epidemiology, pathophysiology, genetic etiology, and management of phenylketonuria (PKU). PKU, an autosomal recessive disease, is an inborn error of phenylalanine (Phe) metabolism caused by pathogenic variants in the phenylalanine hydroxylase (\n                    <jats:italic>PAH<\/jats:italic>\n                    ) gene. The prevalence of PKU varies widely among ethnicities and geographic regions, affecting approximately 1 in 24,000 individuals worldwide. Deficiency in the PAH enzyme or, in rare cases, the cofactor tetrahydrobiopterin results in high blood Phe concentrations, causing brain dysfunction. Untreated PKU, also known as PAH deficiency, results in severe and irreversible intellectual disability, epilepsy, behavioral disorders, and clinical features such as acquired microcephaly, seizures, psychological signs, and generalized hypopigmentation of skin (including hair and eyes). Severe phenotypes are classic PKU, and less severe forms of PAH deficiency are moderate PKU, mild PKU, mild hyperphenylalaninaemia (HPA), or benign HPA. Early diagnosis and intervention must start shortly after birth to prevent major cognitive and neurological effects. Dietary treatment, including natural protein restriction and Phe-free supplements, must be used to maintain blood Phe concentrations of 120\u2013360\u00a0\u03bcmol\/L throughout the life span. Additional treatments include the casein glycomacropeptide (GMP), which contains very limited aromatic amino acids and may improve immunological function, and large neutral amino acid (LNAA) supplementation to prevent plasma Phe transport into the brain. The synthetic BH4 analog, sapropterin hydrochloride (i.e., Kuvan\u00ae, BioMarin), is another potential treatment that activates residual PAH, thus decreasing Phe concentrations in the blood of PKU patients. Moreover, daily subcutaneous injection of pegylated Phe ammonia-lyase (i.e., pegvaliase; PALYNZIQ\u00ae, BioMarin) has promised gene therapy in recent clinical trials, and mRNA approaches are also being studied.\n                  <\/jats:p>","DOI":"10.1186\/s40246-022-00398-9","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:02:54Z","timestamp":1658188974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Genetic etiology and clinical challenges of phenylketonuria"],"prefix":"10.1186","volume":"16","author":[{"given":"Nasser A.","family":"Elhawary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad A.","family":"AlJahdali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman S.","family":"Abumansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzeldin N.","family":"Elhawary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa","family":"Gaboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Dandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulelah","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzia","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab M.","family":"Melibary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Kensara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"issue":"2","key":"398_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","volume":"107","author":"A Hillert","year":"2020","unstructured":"Hillert A, Anikster Y, Belanger-Quintana A, Burlina A, Burton BK, Carducci C, Chiesa AE, Christodoulou J, Dordevic M, Desviat LR, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234\u201350.","journal-title":"Am J Hum Genet"},{"issue":"Suppl 2","key":"398_CR2","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1007\/s10545-010-9091-9","volume":"33","author":"JL Dhondt","year":"2010","unstructured":"Dhondt JL. Lessons from 30 years of selective screening for tetrahydrobiopterin deficiency. J Inherit Metab Dis. 2010;33(Suppl 2):S219\u201323.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"398_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1517\/17425255.2013.804064","volume":"9","author":"N Blau","year":"2013","unstructured":"Blau N. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias. Expert Opin Drug Metab Toxicol. 2013;9(9):1207\u201318.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"398_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ajhg.2017.01.002","volume":"100","author":"Y Anikster","year":"2017","unstructured":"Anikster Y, Haack TB, Vilboux T, Pode-Shakked B, Thony B, Shen N, Guarani V, Meissner T, Mayatepek E, Trefz FK, et al. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet. 2017;100(2):257\u201366.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"398_CR5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ana.25048","volume":"82","author":"L Straniero","year":"2017","unstructured":"Straniero L, Guella I, Cilia R, Parkkinen L, Rimoldi V, Young A, Asselta R, Solda G, Sossi V, Stoessl AJ, et al. DNAJC12 and dopa-responsive nonprogressive parkinsonism. Ann Neurol. 2017;82(4):640\u20136.","journal-title":"Ann Neurol"},{"issue":"2","key":"398_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1542\/peds.2008-1485","volume":"122","author":"G Co","year":"2008","unstructured":"Co G. Maternal phenylketonuria. Pediatrics. 2008;122(2):445\u20139.","journal-title":"Pediatrics"},{"issue":"9750","key":"398_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417\u201327.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"398_CR8","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","volume":"99","author":"MJ de Groot","year":"2010","unstructured":"de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ. Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab. 2010;99(Suppl 1):S86\u20139.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"398_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","volume":"13","author":"JJ Mitchell","year":"2011","unstructured":"Mitchell JJ, Trakadis YJ, Scriver CR. Phenylalanine hydroxylase deficiency. Genet Med. 2011;13(8):697\u2013707.","journal-title":"Genet Med"},{"issue":"1","key":"398_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10545-008-0937-3","volume":"32","author":"FJ van Spronsen","year":"2009","unstructured":"van Spronsen FJ, van Rijn M, Dorgelo B, Hoeksma M, Bosch AM, Mulder MF, de Klerk JB, de Koning T, Rubio-Gozalbo ME, de Vries M, et al. Phenylalanine tolerance can already reliably be assessed at the age of 2 years in patients with PKU. J Inherit Metab Dis. 2009;32(1):27\u201331.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"398_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","volume":"7","author":"FJ van Spronsen","year":"2021","unstructured":"van Spronsen FJ, Blau N, Harding C, Burlina A, Longo N, Bosch AM. Phenylketonuria. Nat Rev Dis Primers. 2021;7(1):36.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"398_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","volume":"5","author":"FJ van Spronsen","year":"2017","unstructured":"van Spronsen FJ, van Wegberg AM, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gizewska M, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"398_CR13","first-page":"63","volume":"11","author":"KM Sumaily","year":"2017","unstructured":"Sumaily KM, Mujamammi AH. Phenylketonuria: A new look at an old topic, advances in laboratory diagnosis, and therapeutic strategies. Int J Health Sci (Qassim). 2017;11(5):63\u201370.","journal-title":"Int J Health Sci (Qassim)"},{"issue":"2","key":"398_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jimd.12186","volume":"43","author":"ER Vardy","year":"2020","unstructured":"Vardy ER, MacDonald A, Ford S, Hofman DL. Phenylketonuria, co-morbidity, and ageing: A review. J Inherit Metabol Dis. 2020;43(2):167\u201378.","journal-title":"J Inherit Metabol Dis"},{"issue":"3","key":"398_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41436-018-0081-x","volume":"21","author":"SF Garbade","year":"2019","unstructured":"Garbade SF, Shen N, Himmelreich N, Haas D, Trefz FK, Hoffmann GF, Burgard P, Blau N. Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria. Genet Med. 2019;21(3):580\u201390.","journal-title":"Genet Med"},{"issue":"1","key":"398_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1076\/jhin.12.1.44.13788","volume":"12","author":"SE Christ","year":"2003","unstructured":"Christ SE. Asbjorn Folling and the discovery of phenylketonuria. J Hist Neurosci. 2003;12(1):44\u201354.","journal-title":"J Hist Neurosci"},{"issue":"3","key":"398_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/ijns6030061","volume":"6","author":"JR Alonso-Fernandez","year":"2020","unstructured":"Alonso-Fernandez JR, Woolf DLI. At the forefront of newborn screening and the diet to treat phenylketonuria-biography to mark his 100th birthday. Int J Neonatal Screen. 2020;6(3):61.","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"398_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/humu.20526","volume":"28","author":"CR Scriver","year":"2007","unstructured":"Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat. 2007;28(9):831\u201345.","journal-title":"Hum Mutat"},{"issue":"2","key":"398_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/2230-8210.81941","volume":"15","author":"Y Sutivijit","year":"2011","unstructured":"Sutivijit Y, Banpavichit A, Wiwanitkit V. Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: A 10-year report. Indian J Endocrinol Metab. 2011;15(2):115\u20137.","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"398_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/humu.1380010307","volume":"1","author":"Y Okano","year":"1992","unstructured":"Okano Y, Hase Y, Lee DH, Furuyama J, Shintaku H, Oura T, Isshiki G. Frequency and distribution of phenylketonuric mutations in Orientals. Hum Mutat. 1992;1(3):216\u201320.","journal-title":"Hum Mutat"},{"key":"398_CR21","first-page":"36","volume":"43","author":"C Silao","year":"2009","unstructured":"Silao C. Mutations of the phenylalanine hydroxylase (PAH) gene in Filipino patients with phenylketonuria. Acta Med Philipp. 2009;43:36\u20139.","journal-title":"Acta Med Philipp"},{"issue":"1\u20132","key":"398_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ymgme.2014.07.018","volume":"113","author":"JS Lim","year":"2014","unstructured":"Lim JS, Tan ES, John CM, Poh S, Yeo SJ, Ang JS, Adakalaisamy P, Rozalli RA, Hart C, Tan ET, et al. Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI\/MS\/MS): An 8 year journey from pilot to current program. Mol Genet Metab. 2014;113(1\u20132):53\u201361.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"398_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031474","volume":"9","author":"L Xiang","year":"2019","unstructured":"Xiang L, Tao J, Deng K, Li X, Li Q, Yuan X, Liang J, Yu E, Wang M, Wang H, et al. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study. BMJ Open. 2019;9(8): e031474.","journal-title":"BMJ Open"},{"key":"398_CR24","doi-asserted-by":"publisher","first-page":"A385","DOI":"10.1016\/j.jval.2013.08.361","volume":"16","author":"G ElSisi","year":"2013","unstructured":"ElSisi G, Elmahdawy M, Abaza S, Shalakani A. Cost-effectiveness of sapropterin versus phenylalanine free diet in patients with phenylketonuria in Egypt. Value in Health. 2013;16:A385.","journal-title":"Value in Health"},{"key":"398_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymgmr.2015.01.001","volume":"2","author":"A Setoodeh","year":"2015","unstructured":"Setoodeh A, Yarali B, Rabbani A, Khatami S, Shams S. Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran. Mol Genet Metab Rep. 2015;2:77\u20139.","journal-title":"Mol Genet Metab Rep"},{"key":"398_CR26","doi-asserted-by":"publisher","first-page":"7697210","DOI":"10.1155\/2018\/7697210","volume":"2018","author":"A El-Metwally","year":"2018","unstructured":"El-Metwally A, Yousef Al-Ahaidib L, Ayman Sunqurah A, Al-Surimi K, Househ M, Alshehri A, Da\u2019ar OB, Abdul Razzak H, AlOdaib AN. The prevalence of phenylketonuria in Arab countries, Turkey, and Iran: A systematic review. Biomed Res Int. 2018;2018:7697210.","journal-title":"Biomed Res Int"},{"issue":"2","key":"398_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2010.11.158","volume":"102","author":"SF Dobrowolski","year":"2011","unstructured":"Dobrowolski SF, Heintz C, Miller T, Ellingson C, Ellingson C, Ozer I, Gokcay G, Baykal T, Thony B, Demirkol M, et al. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population. Mol Genet Metab. 2011;102(2):116\u201321.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"398_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jpc.13469","volume":"53","author":"M Alfadhel","year":"2017","unstructured":"Alfadhel M, Al Othaim A, Al Saif S, Al Mutairi F, Alsayed M, Rahbeeni Z, Alzaidan H, Alowain M, Al-Hassnan Z, Saeedi M, et al. Expanded newborn screening program in Saudi Arabia: Incidence of screened disorders. J Paediatr Child Health. 2017;53(6):585\u201391.","journal-title":"J Paediatr Child Health"},{"key":"398_CR29","first-page":"29","volume":"3","author":"LA Alkhazrajy","year":"2015","unstructured":"Alkhazrajy LA, Hassan AA. Evaluation of neonatal screening program applied at primary health care centers in Baghdad\/Iraq. Eur J Biol Med Sci Res. 2015;3:29\u201347.","journal-title":"Eur J Biol Med Sci Res"},{"issue":"1","key":"398_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.26719\/2014.20.1.17","volume":"20","author":"H Al Hosani","year":"2014","unstructured":"Al Hosani H, Salah M, Osman HM, Farag HM, El-Assiouty L, Saade D, Hertecant J. Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011. East Mediterr Health J. 2014;20(1):17\u201323.","journal-title":"East Mediterr Health J"},{"issue":"1\u20132","key":"398_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ymgme.2013.07.006","volume":"110","author":"J Golbahar","year":"2013","unstructured":"Golbahar J, Al-Jishi EA, Altayab DD, Carreon E, Bakhiet M, Alkhayyat H. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain. Mol Genet Metab. 2013;110(1\u20132):98\u2013101.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"398_CR32","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1086\/302952","volume":"66","author":"JR Kidd","year":"2000","unstructured":"Kidd JR, Pakstis AJ, Zhao H, Lu RB, Okonofua FE, Odunsi A, Grigorenko E, Tamir BB, Friedlaender J, Schulz LO, et al. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet. 2000;66(6):1882\u201399.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"398_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/gtmb.2010.0157","volume":"15","author":"EH Jiffri","year":"2011","unstructured":"Jiffri EH, Elhawary NA. The impact of common tumor necrosis factor haplotypes on the development of asthma in children: An Egyptian model. Genet Test Mol Biomarkers. 2011;15(5):293\u20139.","journal-title":"Genet Test Mol Biomarkers"},{"key":"398_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/821827","volume":"2015","author":"AH Arab","year":"2015","unstructured":"Arab AH, Elhawary NA. Association between ANKK1 (rs1800497) and LTA (rs909253) Genetic variants and risk of Schizophrenia. Biomed Res Int. 2015;2015: 821827.","journal-title":"Biomed Res Int"},{"key":"398_CR35","doi-asserted-by":"publisher","first-page":"1474560","DOI":"10.1155\/2017\/1474560","volume":"2017","author":"NA Elhawary","year":"2017","unstructured":"Elhawary NA, Nassir A, Saada H, Dannoun A, Qoqandi O, Alsharif A, Tayeb MT. Combined genetic biomarkers confer susceptibility to risk of urothelial bladder carcinoma in a Saudi population. Dis Markers. 2017;2017:1474560.","journal-title":"Dis Markers"},{"issue":"1","key":"398_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40246-018-0152-8","volume":"12","author":"NA Elhawary","year":"2018","unstructured":"Elhawary NA, Jiffri EH, Jambi S, Mufti AH, Dannoun A, Kordi H, Khogeer A, Jiffri OH, Elhawary AN, Tayeb MT. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community. Hum Genomics. 2018;12(1):18.","journal-title":"Hum Genomics"},{"key":"398_CR37","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.2147\/IJGM.S341079","volume":"14","author":"AH Mufti","year":"2021","unstructured":"Mufti AH, AlJahdali IA, Elhawary NA, Ekram SN, Abumansour I, Sindi IA, Naffadi H, Elhawary EN, Alyamani NM, Alghamdi G, et al. Variations in TAP1 and PSMB9 genes involved in antigen processing and presentation increase the risk of vitiligo in the Saudi community. Int J Gen Med. 2021;14:10031\u201344.","journal-title":"Int J Gen Med"},{"issue":"1","key":"398_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-021-01846-w","volume":"16","author":"X Wang","year":"2021","unstructured":"Wang X, Wang Y, Ma D, Zhang Z, Li Y, Yang P, Sun Y, Jiang T. Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population. Orphanet J Rare Dis. 2021;16(1):214.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"398_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5144\/0256-4947.2022.29","volume":"42","author":"M Aleissa","year":"2022","unstructured":"Aleissa M, Aloraini T, Alsubaie LF, Hassoun M, Abdulrahman G, Swaid A, Eyaid WA, Mutairi FA, Ababneh F, Alfadhel M, et al. Common disease-associated gene variants in a Saudi Arabian population. Ann Saudi Med. 2022;42(1):29\u201335.","journal-title":"Ann Saudi Med"},{"issue":"4","key":"398_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10545-007-0669-9","volume":"30","author":"GJ Borrajo","year":"2007","unstructured":"Borrajo GJ. Newborn screening in latin America at the beginning of the 21st century. J Inherit Metab Dis. 2007;30(4):466\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"Pt 1","key":"398_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3470001","volume":"347","author":"B Thony","year":"2000","unstructured":"Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J. 2000;347(Pt 1):1\u201316.","journal-title":"Biochem J"},{"key":"398_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainresbull.2013.10.003","volume":"99","author":"M Stevenson","year":"2013","unstructured":"Stevenson M, McNaughton N. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes? Brain Res Bull. 2013;99:63\u201383.","journal-title":"Brain Res Bull"},{"issue":"1","key":"398_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2021.02.008","volume":"133","author":"A van Wegberg","year":"2021","unstructured":"van Wegberg A, Evers R, Burgerhof J, van Dam E, Heiner-Fokkema MR, Janssen M, de Vries MC, van Spronsen FJ. Effect of BH4 on blood phenylalanine and tyrosine variations in patients with phenylketonuria. Mol Genet Metab. 2021;133(1):49\u201355.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"398_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/sj.jcbfm.9600571","volume":"28","author":"C Landvogt","year":"2008","unstructured":"Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, et al. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. J Cereb Blood Flow Metab. 2008;28(4):824\u201331.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"398_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA, et al. Phenylalanine hydroxylase deficiency: Diagnosis and management guideline. Genet Med. 2014;16(2):188\u2013200.","journal-title":"Genet Med"},{"key":"398_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpn.2020.07.011","volume":"28","author":"F Porta","year":"2020","unstructured":"Porta F, Ponzone A, Spada M. Phenylalanine and tyrosine metabolism in DNAJC12 deficiency: A comparison between inherited hyperphenylalaninemias and healthy subjects. Eur J Paediatr Neurol. 2020;28:77\u201380.","journal-title":"Eur J Paediatr Neurol"},{"issue":"14","key":"398_CR47","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1016\/j.febslet.2006.05.026","volume":"580","author":"C Hartwig","year":"2006","unstructured":"Hartwig C, Gal A, Santer R, Ullrich K, Finckh U, Kreienkamp HJ. Elevated phenylalanine levels interfere with neurite outgrowth stimulated by the neuronal cell adhesion molecule L1 in vitro. FEBS Lett. 2006;580(14):3489\u201392.","journal-title":"FEBS Lett"},{"issue":"4 Pt 1","key":"398_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1203\/01.pdr.0000203091.45988.8d","volume":"59","author":"F Horster","year":"2006","unstructured":"Horster F, Schwab MA, Sauer SW, Pietz J, Hoffmann GF, Okun JG, Kolker S, Kins S. Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr Res. 2006;59(4 Pt 1):544\u20138.","journal-title":"Pediatr Res"},{"key":"398_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.expneurol.2016.04.013","volume":"281","author":"G Schlegel","year":"2016","unstructured":"Schlegel G, Scholz R, Ullrich K, Santer R, Rune GM. Phenylketonuria: Direct and indirect effects of phenylalanine. Exp Neurol. 2016;281:28\u201336.","journal-title":"Exp Neurol"},{"issue":"1","key":"398_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2016.02.004","volume":"118","author":"SE Christ","year":"2016","unstructured":"Christ SE, Price MH, Bodner KE, Saville C, Moffitt AJ, Peck D. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Mol Genet Metab. 2016;118(1):3\u20138.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"398_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jimd.12049","volume":"42","author":"A Pilotto","year":"2019","unstructured":"Pilotto A, Blau N, Leks E, Schulte C, Deuschl C, Zipser C, Piel D, Freisinger P, Gramer G, Kolker S, et al. Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria. J Inherit Metab Dis. 2019;42(3):398\u2013406.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"398_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10545-010-9052-3","volume":"33","author":"R Schoemans","year":"2010","unstructured":"Schoemans R, Aigrot MS, Wu C, Maree R, Hong P, Belachew S, Josse C, Lubetzki C, Bours V. Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. J Inherit Metab Dis. 2010;33(2):113\u201320.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"398_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","volume":"61","author":"S Shefer","year":"2000","unstructured":"Shefer S, Tint GS, Jean-Guillaume D, Daikhin E, Kendler A, Nguyen LB, Yudkoff M, Dyer CA. Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res. 2000;61(5):549\u201363.","journal-title":"J Neurosci Res"},{"key":"398_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1750-1172-8-133","volume":"8","author":"MJ de Groot","year":"2013","unstructured":"de Groot MJ, Hoeksma M, Reijngoud DJ, de Valk HW, Paans AM, Sauer PJ, van Spronsen FJ. Phenylketonuria: Reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis. 2013;8:133.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"398_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","volume":"112","author":"KM Camp","year":"2014","unstructured":"Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, et al. Phenylketonuria scientific review conference: State of the science and future research needs. Mol Genet Metab. 2014;112(2):87\u2013122.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"398_CR56","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3945\/ajcn.116.135996","volume":"104","author":"D van Vliet","year":"2016","unstructured":"van Vliet D, Bruinenberg VM, Mazzola PN, van Faassen MH, de Blaauw P, Pascucci T, Puglisi-Allegra S, Kema IP, Heiner-Fokkema MR, van der Zee EA, et al. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model. Am J Clin Nutr. 2016;104(5):1292\u2013300.","journal-title":"Am J Clin Nutr"},{"issue":"1 Suppl","key":"398_CR57","doi-asserted-by":"publisher","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","volume":"136","author":"RA Hawkins","year":"2006","unstructured":"Hawkins RA, O\u2019Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136(1 Suppl):218S-S226.","journal-title":"J Nutr"},{"issue":"1","key":"398_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2007.02.002","volume":"91","author":"S Schindeler","year":"2007","unstructured":"Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Mol Genet Metab. 2007;91(1):48\u201354.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"398_CR59","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.ymgme.2009.09.013","volume":"99","author":"KM Antshel","year":"2010","unstructured":"Antshel KM. ADHD, learning, and academic performance in phenylketonuria. Mol Genet Metab. 2010;99(Suppl 1):S52\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"398_CR60","first-page":"31","volume":"29","author":"RA Williams","year":"2008","unstructured":"Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008;29(1):31\u201341.","journal-title":"Clin Biochem Rev"},{"key":"398_CR61","doi-asserted-by":"crossref","unstructured":"Abgottspon S, Muri R, Christ SE, Hochuli M, Radojewski P, Trepp R, Everts R. Neural correlates of working memory and its association with metabolic parameters in early-treated adults with phenylketonuria. NeuroImage: Clinic 2022;34:102974.","DOI":"10.1016\/j.nicl.2022.102974"},{"key":"398_CR62","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.2147\/NDT.S176198","volume":"14","author":"AA Sadek","year":"2018","unstructured":"Sadek AA, Hassan MH, Mohammed NA. Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years. Neuropsychiatr Dis Treat. 2018;14:2551\u201361.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"398_CR63","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2020\/38\/2018351","volume":"38","author":"RD Costa","year":"2020","unstructured":"Costa RD, Galera BB, Rezende BC, Venancio AC, Galera MF. Identification of mutations in the PAH Gene in PKU patients in the state of Mato Grosso. Rev Paul Pediatr. 2020;38: e2018351.","journal-title":"Rev Paul Pediatr"},{"issue":"6","key":"398_CR64","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1586\/14737159.2014.923760","volume":"14","author":"N Blau","year":"2014","unstructured":"Blau N, Shen N, Carducci C. Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn. 2014;14(6):655\u201371.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"398_CR65","doi-asserted-by":"publisher","first-page":"11251","DOI":"10.1038\/s41598-018-29640-y","volume":"8","author":"N Li","year":"2018","unstructured":"Li N, He C, Li J, Tao J, Liu Z, Zhang C, Yuan Y, Jiang H, Zhu J, Deng Y, et al. Analysis of the genotype-phenotype correlation in patients with phenylketonuria in mainland China. Sci Rep. 2018;8(1):11251.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"398_CR66","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/mgme.2001.3213","volume":"74","author":"N Blau","year":"2001","unstructured":"Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: Diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab. 2001;74(1\u20132):172\u201385.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"398_CR67","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.braindev.2014.09.008","volume":"37","author":"B Han","year":"2015","unstructured":"Han B, Zou H, Han B, Zhu W, Cao Z, Liu Y. Diagnosis, treatment and follow-up of patients with tetrahydrobiopterin deficiency in Shandong province. China Brain Dev. 2015;37(6):592\u20138.","journal-title":"China Brain Dev"},{"issue":"12","key":"398_CR68","first-page":"890","volume":"51","author":"N Liu","year":"2016","unstructured":"Liu N, Zhao DH, Li XL, Cui LX, Wu QH, Jiang M, Kong XD. PTPS gene analysis and prenatal diagnosis in patients with 6-pyruvoyl-tetra hydropterin synthase deficiency. Zhonghua Fu Chan Ke Za Zhi. 2016;51(12):890\u20134.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"398_CR69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2019.02.008","volume":"96","author":"M Almannai","year":"2019","unstructured":"Almannai M, Felemban R, Saleh MA, Faqeih EA, Alasmari A, AlHashem A, Mohamed S, Sunbul R, Al-Murshedi F, AlThihli K, et al. 6-Pyruvoyltetrahydropterin synthase deficiency: Review and report of 28 Arab subjects. Pediatr Neurol. 2019;96:40\u20137.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"398_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211048","volume":"14","author":"P Gundorova","year":"2019","unstructured":"Gundorova P, Stepanova AA, Kuznetsova IA, Kutsev SI, Polyakov AV. Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia. PLoS ONE. 2019;14(1): e0211048.","journal-title":"PLoS ONE"},{"key":"398_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/8904_2012_202","volume":"10","author":"CR Coughlin 2nd","year":"2013","unstructured":"Coughlin CR 2nd, Hyland K, Randall R, Ficicioglu C. Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report. JIMD Rep. 2013;10:53\u20136.","journal-title":"JIMD Rep"},{"issue":"2","key":"398_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymgme.2021.04.003","volume":"133","author":"N Himmelreich","year":"2021","unstructured":"Himmelreich N, Blau N, Thony B. Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab. 2021;133(2):123\u201336.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"398_CR73","first-page":"652","volume":"44","author":"SE Sullivan","year":"1989","unstructured":"Sullivan SE, Moore SD, Connor JM, King M, Cockburn F, Steinmann B, Gitzelmann R, Daiger SP, Woo SL. Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet. 1989;44(5):652\u20139.","journal-title":"Am J Hum Genet"},{"issue":"6262","key":"398_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/344168a0","volume":"344","author":"S Avigad","year":"1990","unstructured":"Avigad S, Cohen BE, Bauer S, Schwartz G, Frydman M, Woo SL, Niny Y, Shiloh Y. A single origin of phenylketonuria in Yemenite Jews. Nature. 1990;344(6262):168\u201370.","journal-title":"Nature"},{"issue":"4","key":"398_CR75","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/3.4.659","volume":"3","author":"Y Okano","year":"1994","unstructured":"Okano Y, Hase Y, Shintaku H, Araki K, Furuyama J, Oura T, Isshiki G. Molecular characterization of phenylketonuric mutations in Japanese by analysis of phenylalanine hydroxylase mRNA from lymphoblasts. Hum Mol Genet. 1994;3(4):659.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"398_CR76","first-page":"497","volume":"38","author":"P Bosco","year":"1996","unstructured":"Bosco P, Ceratto N, Cali F, Goltsov AA, Eisensmith RC, Novelli G, Dalla Piccola B, Romano V. RFLP discordance in a PKU family due to a deletion in the PAH gene. Turk J Pediatr. 1996;38(4):497\u2013504.","journal-title":"Turk J Pediatr"},{"issue":"6","key":"398_CR77","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1023\/A:1005352725283","volume":"20","author":"P Guldberg","year":"1997","unstructured":"Guldberg P, Henriksen KF, Mammen KC, Levy HL, Guttler F. Large deletions in the phenylalanine hydroxylase gene as a cause of phenylketonuria in India. J Inherit Metab Dis. 1997;20(6):845\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"398_CR78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1023\/A:1005527731397","volume":"22","author":"J Zschocke","year":"1999","unstructured":"Zschocke J, Quak E, Knauer A, Fritz B, Aslan M, Hoffmann GF. Large heterozygous deletion masquerading as homozygous missense mutation: A pitfall in diagnostic mutation analysis. J Inherit Metab Dis. 1999;22(6):687\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"398_CR79","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.10199","volume":"21","author":"M Gable","year":"2003","unstructured":"Gable M, Williams M, Stephenson A, Okano Y, Ring S, Hurtubise M, Tyfield L. Comparative multiplex dosage analysis detects whole exon deletions at the phenylalanine hydroxylase locus. Hum Mutat. 2003;21:379\u201386.","journal-title":"Hum Mutat"},{"issue":"5","key":"398_CR80","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3858\/emm.2008.40.5.533","volume":"40","author":"YW Lee","year":"2008","unstructured":"Lee YW, Lee DH, Kim ND, Lee ST, Ahn JY, Choi TY, Lee YK, Kim SH, Kim JW, Ki CS. Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria. Exp Mol Med. 2008;40(5):533\u201340.","journal-title":"Exp Mol Med"},{"issue":"1 Pt 1","key":"398_CR81","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.gene.2015.10.020","volume":"576","author":"C Gemperle-Britschgi","year":"2016","unstructured":"Gemperle-Britschgi C, Iorgulescu D, Mager MA, Anton-Paduraru D, Vulturar R, Thony B. A novel common large genomic deletion and two new missense mutations identified in the Romanian phenylketonuria population. Gene. 2016;576(1 Pt 1):182\u20138.","journal-title":"Gene"},{"issue":"3","key":"398_CR82","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11011-019-0387-7","volume":"34","author":"Y Yan","year":"2019","unstructured":"Yan Y, Zhang C, Jin X, Zhang Q, Zheng L, Feng X, Hao S, Gao H, Ma X. Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: Identification of twenty novel variants. Metab Brain Dis. 2019;34(3):733\u201345.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"398_CR83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13059-017-1158-6","volume":"18","author":"RL Collins","year":"2017","unstructured":"Collins RL, Brand H, Redin CE, Hanscom C, Antolik C, Stone MR, Glessner JT, Mason T, Pregno G, Dorrani N, et al. Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome. Genome Biol. 2017;18(1):36.","journal-title":"Genome Biol"},{"issue":"1","key":"398_CR84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13073-018-0606-6","volume":"10","author":"A Sanchis-Juan","year":"2018","unstructured":"Sanchis-Juan A, Stephens J, French CE, Gleadall N, Megy K, Penkett C, Shamardina O, Stirrups K, Delon I, Dewhurst E, et al. Complex structural variants in mendelian disorders: identification and breakpoint resolution using short- and long-read genome sequencing. Genome Med. 2018;10(1):95.","journal-title":"Genome Med"},{"key":"398_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/8904_2018_108","volume":"43","author":"K Yokoi","year":"2019","unstructured":"Yokoi K, Nakajima Y, Ohye T, Inagaki H, Wada Y, Fukuda T, Sugie H, Yuasa I, Ito T, Kurahashi H. Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion. JIMD Rep. 2019;43:85\u201390.","journal-title":"JIMD Rep"},{"issue":"4","key":"398_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1154","volume":"8","author":"H Lillevali","year":"2020","unstructured":"Lillevali H, Pajusalu S, Wojcik MH, Goodrich J, Collins RL, Murumets U, Tammur P, Blau N, Lillevali K, Ounap K. Genome sequencing identifies a homozygous inversion disrupting QDPR as a cause for dihydropteridine reductase deficiency. Mol Genet Genomic Med. 2020;8(4): e1154.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"398_CR87","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ymgme.2006.06.007","volume":"89","author":"L Kozak","year":"2006","unstructured":"Kozak L, Hrabincova E, Kintr J, Horky O, Zapletalova P, Blahakova I, Mejstrik P, Prochazkova D. Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: evidence for both homologous and non-homologous mechanisms of rearrangement. Mol Genet Metab. 2006;89(4):300\u20139.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"398_CR88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/jhg.2011.146","volume":"57","author":"YH Chiu","year":"2012","unstructured":"Chiu YH, Chang YC, Chang YH, Niu DM, Yang YL, Ye J, Jiang J, Okano Y, Lee DH, Pangkanon S, et al. Mutation spectrum of and founder effects affecting the PTS gene in East Asian populations. J Hum Genet. 2012;57(2):145\u201352.","journal-title":"J Hum Genet"},{"issue":"3","key":"398_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/jhg.2013.136","volume":"59","author":"Y Liang","year":"2014","unstructured":"Liang Y, Huang MZ, Cheng CY, Chao HK, Fwu VT, Chiang SH, Hsiao KJ, Niu DM, Su TS. The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese population. J Hum Genet. 2014;59(3):145\u201352.","journal-title":"J Hum Genet"},{"issue":"6","key":"398_CR90","first-page":"349","volume":"97","author":"KE Oddason","year":"2011","unstructured":"Oddason KE, Eiriksdottir L, Franzson L, Dagbjartsson A. Phenylketonuria (PKU) in Iceland. Laeknabladid. 2011;97(6):349\u201352.","journal-title":"Laeknabladid"},{"issue":"12","key":"398_CR91","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/jmg.32.12.976","volume":"32","author":"P Guldberg","year":"1995","unstructured":"Guldberg P, Henriksen KF, Sipila I, Guttler F, de la Chapelle A. Phenylketonuria in a low incidence population: Molecular characterisation of mutations in Finland. J Med Genet. 1995;32(12):976\u20138.","journal-title":"J Med Genet"},{"issue":"2","key":"398_CR92","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1752-4571.2010.00181.x","volume":"4","author":"RM Nesse","year":"2011","unstructured":"Nesse RM. Ten questions for evolutionary studies of disease vulnerability. Evol Appl. 2011;4(2):264\u201377.","journal-title":"Evol Appl"},{"key":"398_CR93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1471-2350-12-160","volume":"12","author":"AJ Carter","year":"2011","unstructured":"Carter AJ, Nguyen AQ. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet. 2011;12:160.","journal-title":"BMC Med Genet"},{"key":"398_CR94","first-page":"73","volume":"197","author":"CR Scriver","year":"1996","unstructured":"Scriver CR, Byck S, Prevost L, Hoang L. The phenylalanine hydroxylase locus: A marker for the history of phenylketonuria and human genetic diversity PAH mutation analysis consortium. Ciba Found Symp. 1996;197:73\u201390.","journal-title":"Ciba Found Symp"},{"issue":"8","key":"398_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042553","volume":"7","author":"DD Wu","year":"2012","unstructured":"Wu DD, Li GM, Jin W, Li Y, Zhang YP. Positive selection on the osteoarthritis-risk and decreased-height associated variants at the GDF5 gene in East Asians. PLoS ONE. 2012;7(8): e42553.","journal-title":"PLoS ONE"},{"issue":"2","key":"398_CR96","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/molbev\/msx305","volume":"35","author":"K Voskarides","year":"2018","unstructured":"Voskarides K. Combination of 247 genome-wide association studies reveals high cancer risk as a result of evolutionary adaptation. Mol Biol Evol. 2018;35(2):473\u201385.","journal-title":"Mol Biol Evol"},{"issue":"1","key":"398_CR97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/emph\/eoy033","volume":"2018","author":"SN Austad","year":"2018","unstructured":"Austad SN, Hoffman JM. Is antagonistic pleiotropy ubiquitous in aging biology? Evol Med Public Health. 2018;2018(1):287\u201394.","journal-title":"Evol Med Public Health"},{"issue":"1","key":"398_CR98","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00239-019-09923-2","volume":"88","author":"SG Byars","year":"2020","unstructured":"Byars SG, Voskarides K. Antagonistic pleiotropy in human disease. J Mol Evol. 2020;88(1):12\u201325.","journal-title":"J Mol Evol"},{"issue":"5","key":"398_CR99","first-page":"773","volume":"38","author":"LI Woolf","year":"1986","unstructured":"Woolf LI. The heterozygote advantage in phenylketonuria. Am J Hum Genet. 1986;38(5):773\u20135.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"398_CR100","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41390-021-01728-8","volume":"91","author":"GB Liemburg","year":"2022","unstructured":"Liemburg GB, Huijbregts SCJ, Rutsch F, Feldmann R, Jahja R, Weglage J, Och U, Burgerhof JGM, van Spronsen FJ. Metabolic control during the neonatal period in phenylketonuria: associations with childhood IQ. Pediatr Res. 2022;91(4):874\u20138.","journal-title":"Pediatr Res"},{"issue":"7","key":"398_CR101","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0168-9525(99)01761-8","volume":"15","author":"CR Scriver","year":"1999","unstructured":"Scriver CR, Waters PJ. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 1999;15(7):267\u201372.","journal-title":"Trends Genet"},{"key":"398_CR102","doi-asserted-by":"crossref","unstructured":"Djordjevic M, Klaassen K, Sarajlija A, Tosic N, Zukic B, Kecman B, Ugrin M, Spasovski V, Pavlovic S, Stojiljkovic M. Molecular genetics and genotype-based estimation of BH4-responsiveness in Serbian PKU patients: Spotlight on Phenotypic Implications of p.L48S. JIMD Rep. 2013;9:49\u201358.","DOI":"10.1007\/8904_2012_178"},{"issue":"1\u20132","key":"398_CR103","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/mgme.2000.3052","volume":"71","author":"KM Dipple","year":"2000","unstructured":"Dipple KM, McCabe ER. Modifier genes convert \u201csimple\u201d mendelian disorders to complex traits. Mol Genet Metab. 2000;71(1\u20132):43\u201350.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"398_CR104","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-018-0890-7","volume":"13","author":"D van Vliet","year":"2018","unstructured":"van Vliet D, van Wegberg AMJ, Ahring K, Bik-Multanowski M, Blau N, Bulut FD, Casas K, Didycz B, Djordjevic M, Federico A, et al. Can untreated PKU patients escape from intellectual disability? A systematic review. Orphanet J Rare Dis. 2018;13(1):149.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"398_CR105","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1086\/302938","volume":"66","author":"KM Dipple","year":"2000","unstructured":"Dipple KM, McCabe ER. Phenotypes of patients with \u201csimple\u201d mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics. Am J Hum Genet. 2000;66(6):1729\u201335.","journal-title":"Am J Hum Genet"},{"key":"398_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2021.100822","volume":"29","author":"K Klaassen","year":"2021","unstructured":"Klaassen K, Djordjevic M, Skakic A, Kecman B, Drmanac R, Pavlovic S, Stojiljkovic M. Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier. Mol Genet Metab Rep. 2021;29: 100822.","journal-title":"Mol Genet Metab Rep"},{"key":"398_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2021.100751","volume":"27","author":"M Bik-Multanowski","year":"2021","unstructured":"Bik-Multanowski M, Bik-Multanowska K, Betka I, Madetko-Talowska A. The rs113883650 variant of SLC7A5 (LAT1) gene may alter brain phenylalanine content in PKU. Mol Genet Metab Rep. 2021;27: 100751.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"398_CR108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jmedgenet-2014-102621","volume":"52","author":"MK Danecka","year":"2015","unstructured":"Danecka MK, Woidy M, Zschocke J, Feillet F, Muntau AC, Gersting SW. Mapping the functional landscape of frequent phenylalanine hydroxylase (PAH) genotypes promotes personalised medicine in phenylketonuria. J Med Genet. 2015;52(3):175\u201385.","journal-title":"J Med Genet"},{"key":"398_CR109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/8904_2011_96","volume":"5","author":"CN Sarkissian","year":"2012","unstructured":"Sarkissian CN, Gamez A, Scott P, Dauvillier J, Dorenbaum A, Scriver CR, Stevens RC. Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response? JIMD Rep. 2012;5:59\u201370.","journal-title":"JIMD Rep"},{"issue":"1","key":"398_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1086\/301920","volume":"63","author":"P Guldberg","year":"1998","unstructured":"Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet. 1998;63(1):71\u20139.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"398_CR111","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.kjms.2017.09.006","volume":"34","author":"ZW Wang","year":"2018","unstructured":"Wang ZW, Jiang SW, Zhou BC. PAH mutation spectrum and correlation with PKU manifestation in north Jiangsu province population. Kaohsiung J Med Sci. 2018;34(2):89\u201394.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1\u20132","key":"398_CR112","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ymgme.2018.06.011","volume":"125","author":"N Himmelreich","year":"2018","unstructured":"Himmelreich N, Shen N, Okun JG, Thiel C, Hoffmann GF, Blau N. Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria. Mol Genet Metab. 2018;125(1\u20132):86\u201395.","journal-title":"Mol Genet Metab"},{"key":"398_CR113","doi-asserted-by":"publisher","DOI":"10.1590\/2326-4594-jiems-2019-0012","author":"RE Enac\u00e1n","year":"2019","unstructured":"Enac\u00e1n RE, Mi\u00f1ana MN, Fernandez L, Valle MG, Salerno M, Fraga CI, Santos-Simarro F, Prieto L, Lapunzina P, Specola N, et al. Phenylalanine hydroxylase (PAH) genotyping in PKU Argentine Patients. J Inborn Errors Metabol Screen. 2019. https:\/\/doi.org\/10.1590\/2326-4594-jiems-2019-0012.","journal-title":"J Inborn Errors Metabol Screen."},{"issue":"3","key":"398_CR114","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ymgme.2016.01.004","volume":"117","author":"N Shen","year":"2016","unstructured":"Shen N, Heintz C, Thiel C, Okun JG, Hoffmann GF, Blau N. Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation. Mol Genet Metab. 2016;117(3):328\u201335.","journal-title":"Mol Genet Metab"},{"key":"398_CR115","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13023-016-0394-2","volume":"11","author":"K Anjema","year":"2016","unstructured":"Anjema K, Hofstede FC, Bosch AM, Rubio-Gozalbo ME, de Vries MC, Boelen CC, van Rijn M, van Spronsen FJ. The neonatal tetrahydrobiopterin loading test in phenylketonuria: What is the predictive value? Orphanet J Rare Dis. 2016;11:10.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"398_CR116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1006\/geno.1993.1295","volume":"17","author":"P Guldberg","year":"1993","unstructured":"Guldberg P, Henriksen KF, Guttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics. 1993;17(1):141\u20136.","journal-title":"Genomics"},{"key":"398_CR117","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ymgme.2014.10.004","volume":"113","author":"YY Cao","year":"2014","unstructured":"Cao YY, Qu YJ, Song F, Zhang T, Bai JL, Jin YW, Wang H. Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeqTM panel and Ion Torrent PGM sequencing. Mol Genet Metab. 2014;113:261\u20136.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"398_CR118","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ejhg.2013.175","volume":"22","author":"D Trujillano","year":"2014","unstructured":"Trujillano D, Perez B, Gonzalez J, Tornador C, Navarrete R, Escaramis G, Ossowski S, Armengol L, Cornejo V, Desviat LR, et al. Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing. Eur J Hum Genet. 2014;22(4):528\u201334.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"398_CR119","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1515\/jpem-2021-0556","volume":"35","author":"FN Ozturk","year":"2022","unstructured":"Ozturk FN, Akin DT. An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey. J Pediatr Endocrinol Metab. 2022;35(5):663\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"398_CR120","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2021.10.009","volume":"523","author":"B Shao","year":"2021","unstructured":"Shao B, Liu A, Zhang J, Wang Y, Qiao F, Zhang C, Zhu Y, Lin Y, Hu P, Tao T, et al. A capillary electrophoresis-based variant hotspot genotyping method for rapid and reliable analysis of the phenylalanine hydroxylase gene in the Chinese Han population. Clin Chim Acta. 2021;523:267\u201372.","journal-title":"Clin Chim Acta"},{"key":"398_CR121","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clinbiochem.2017.10.016","volume":"52","author":"A Smon","year":"2018","unstructured":"Smon A, Repic Lampret B, Groselj U, Zerjav Tansek M, Kovac J, Perko D, Bertok S, Battelino T, Trebusak PK. Next generation sequencing as a follow-up test in an expanded newborn screening programme. Clin Biochem. 2018;52:48\u201355.","journal-title":"Clin Biochem"},{"issue":"4","key":"398_CR122","first-page":"256","volume":"59","author":"BR Lampret","year":"2020","unstructured":"Lampret BR, Remec ZI, Torkar AD, Tansek MZ, Smon A, Koracin V, Cuk V, Perko D, Ulaga B, Jelovsek AM, et al. Expanded newborn screening program in slovenia using tandem mass spectrometry and confirmatory next generation sequencing genetic testing. Zdr Varst. 2020;59(4):256\u201363.","journal-title":"Zdr Varst"},{"key":"398_CR123","doi-asserted-by":"publisher","first-page":"662254","DOI":"10.3389\/fgene.2021.662254","volume":"12","author":"ZI Remec","year":"2021","unstructured":"Remec ZI, Trebusak Podkrajsek K, Repic Lampret B, Kovac J, Groselj U, Tesovnik T, Battelino T, Debeljak M. Next-generation sequencing in newborn screening: A review of current state. Front Genet. 2021;12:662254. https:\/\/doi.org\/10.3389\/fgene.2021.662254.","journal-title":"Front Genet"},{"issue":"7","key":"398_CR124","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/JXX.0000000000000631","volume":"33","author":"S White-Corey","year":"2021","unstructured":"White-Corey S, Peck JL, Perez RI. Ethical implications of next-generation sequencing and the future of newborn screening. J Am Assoc Nurse Pract. 2021;33(7):492\u20135.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"1","key":"398_CR125","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1038\/s41598-021-81897-y","volume":"11","author":"R Zhang","year":"2021","unstructured":"Zhang R, Qiang R, Song C, Ma X, Zhang Y, Li F, Wang R, Yu W, Feng M, Yang L, et al. Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population. Sci Rep. 2021;11(1):2699.","journal-title":"Sci Rep"},{"issue":"1","key":"398_CR126","doi-asserted-by":"publisher","first-page":"22886","DOI":"10.1038\/s41598-021-02267-2","volume":"11","author":"R Manek","year":"2021","unstructured":"Manek R, Zhang YV, Berthelette P, Hossain M, Cornell CS, Gans J, Anarat-Cappillino G, Geller S, Jackson R, Yu D, et al. Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria. Sci Rep. 2021;11(1):22886.","journal-title":"Sci Rep"},{"issue":"Suppl","key":"398_CR127","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ymgme.2011.08.025","volume":"104","author":"F Trefz","year":"2011","unstructured":"Trefz F, Maillot F, Motzfeldt K, Schwarz M. Adult phenylketonuria outcome and management. Mol Genet Metab. 2011;104(Suppl):S26-30.","journal-title":"Mol Genet Metab"},{"issue":"Pt 3","key":"398_CR128","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/0004563213503818","volume":"51","author":"D Narayanan","year":"2014","unstructured":"Narayanan D, Barski R, Henderson MJ, Luvai A, Chandrajay D, Stainforth C, Bradley J, Rogozinski H, Sharma R. Delayed diagnosis of phenylketonuria - a case report of two siblings. Ann Clin Biochem. 2014;51(Pt 3):406\u20138.","journal-title":"Ann Clin Biochem"},{"key":"398_CR129","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/8904_2012_207","volume":"10","author":"S Rubin","year":"2013","unstructured":"Rubin S, Piffer AL, Rougier MB, Delyfer MN, Korobelnik JF, Redonnet-Vernhet I, Marchal C, Goizet C, Mesli S, Gonzalez C, et al. Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet. JIMD Rep. 2013;10:83\u20135.","journal-title":"JIMD Rep"},{"issue":"2","key":"398_CR130","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00415-019-09608-2","volume":"267","author":"P Jaulent","year":"2020","unstructured":"Jaulent P, Charriere S, Feillet F, Douillard C, Fouilhoux A, Thobois S. Neurological manifestations in adults with phenylketonuria: New cases and review of the literature. J Neurol. 2020;267(2):531\u201342.","journal-title":"J Neurol"},{"issue":"6","key":"398_CR131","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp.71.6.795","volume":"71","author":"S Kasim","year":"2001","unstructured":"Kasim S, Moo LR, Zschocke J, Jinnah HA. Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia. J Neurol Neurosurg Psychiatry. 2001;71(6):795\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"398_CR132","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1007\/s00415-014-7492-7","volume":"261","author":"F Rosini","year":"2014","unstructured":"Rosini F, Rufa A, Monti L, Tirelli L, Federico A. Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism. J Neurol. 2014;261(12):2446\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"398_CR133","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/mgme.2001.3168","volume":"73","author":"M Lindner","year":"2001","unstructured":"Lindner M, Haas D, Mayatepek E, Zschocke J, Burgard P. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype. Mol Genet Metab. 2001;73(1):104\u20136.","journal-title":"Mol Genet Metab"},{"issue":"26","key":"398_CR134","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa021654","volume":"347","author":"AC Muntau","year":"2002","unstructured":"Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, Roscher AA. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347(26):2122\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"398_CR135","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymgme.2003.11.008","volume":"81","author":"R Cerone","year":"2004","unstructured":"Cerone R, Schiaffino MC, Fantasia AR, Perfumo M, Birk Moller L, Blau N. Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria. Mol Genet Metab. 2004;81(2):137\u20139.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"398_CR136","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.ymgme.2005.09.014","volume":"86","author":"B Fiege","year":"2005","unstructured":"Fiege B, Bonafe L, Ballhausen D, Baumgartner M, Thony B, Meili D, Fiori L, Giovannini M, Blau N. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol Genet Metab. 2005;86(Suppl 1):S91\u20135.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"398_CR137","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.ymgme.2005.06.008","volume":"86","author":"JJ Mitchell","year":"2005","unstructured":"Mitchell JJ, Wilcken B, Alexander I, Ellaway C, O\u2019Grady H, Wiley V, Earl J, Christodoulou J. Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience. Mol Genet Metab. 2005;86(Suppl 1):S81\u20135.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"398_CR138","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/A:1005607115309","volume":"23","author":"J Weglage","year":"2000","unstructured":"Weglage J, Oberwittler C, Marquardt T, Schellscheidt J, von Teeffelen-Heithoff A, Koch G, Gerding H. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis. 2000;23(1):83\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"398_CR139","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gizewska M, et al. The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"398_CR140","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","volume":"30","author":"D Modan-Moses","year":"2007","unstructured":"Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, Efrati O. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007;30(2):202\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"398_CR141","doi-asserted-by":"publisher","first-page":"493","DOI":"10.5114\/aoms.2011.23417","volume":"7","author":"HM Koura","year":"2011","unstructured":"Koura HM, Abdallah Ismail N, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK. A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci. 2011;7(3):493\u2013500.","journal-title":"Arch Med Sci"},{"issue":"1","key":"398_CR142","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","volume":"15","author":"A MacDonald","year":"2020","unstructured":"MacDonald A, van Wegberg AMJ, Ahring K, Beblo S, Belanger-Quintana A, Burlina A, Campistol J, Coskun T, Feillet F, Gizewska M, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):171.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"398_CR143","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jand.2012.05.004","volume":"112","author":"SC van Calcar","year":"2012","unstructured":"van Calcar SC, Ney DM. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino acid-based medical foods for nutrition management of phenylketonuria. J Acad Nutr Diet. 2012;112(8):1201\u201310.","journal-title":"J Acad Nutr Diet"},{"issue":"7","key":"398_CR144","doi-asserted-by":"publisher","first-page":"G590","DOI":"10.1152\/ajpgi.00211.2015","volume":"309","author":"EA Sawin","year":"2015","unstructured":"Sawin EA, De Wolfe TJ, Aktas B, Stroup BM, Murali SG, Steele JL, Ney DM. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol. 2015;309(7):G590-601.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"398_CR145","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3945\/ajcn.116.135293","volume":"104","author":"DM Ney","year":"2016","unstructured":"Ney DM, Stroup BM, Clayton MK, Murali SG, Rice GM, Rohr F, Levy HL. Glycomacropeptide for nutritional management of phenylketonuria: A randomized, controlled, crossover trial. Am J Clin Nutr. 2016;104(2):334\u201345.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"398_CR146","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ejcn.2017.38","volume":"71","author":"A Pinto","year":"2017","unstructured":"Pinto A, Almeida MF, Ramos PC, Rocha S, Guimas A, Ribeiro R, Martins E, Bandeira A, MacDonald A, Rocha JC. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. Eur J Clin Nutr. 2017;71(10):1230\u20134.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"398_CR147","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00005176-199302000-00008","volume":"16","author":"SS Gropper","year":"1993","unstructured":"Gropper SS, Gropper DM, Acosta PB. Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr. 1993;16(2):143\u201350.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"398_CR148","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2","volume":"53","author":"HL Levy","year":"1996","unstructured":"Levy HL, Ghavami M. Maternal phenylketonuria: a metabolic teratogen. Teratology. 1996;53(3):176\u201384.","journal-title":"Teratology"},{"issue":"1","key":"398_CR149","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-3476(00)90050-7","volume":"136","author":"B Rouse","year":"2000","unstructured":"Rouse B, Matalon R, Koch R, Azen C, Levy H, Hanley W, Trefz F, De La Cruz F. Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes. J Pediatr. 2000;136(1):57\u201361.","journal-title":"J Pediatr"},{"key":"398_CR150","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/8904_2014_365","volume":"21","author":"S Waisbren","year":"2014","unstructured":"Waisbren S, Rohr F, Anastasoaie V, Brown M, Harris D, Ozonoff A, Petrides S, Wessel A, Levy H. Maternal phenylketonuria: Long-term outcomes in offspring and post-pregnancy maternal characteristics. JIMD Reports. 2014;21:23\u201333.","journal-title":"JIMD Reports"},{"issue":"5","key":"398_CR151","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1203\/00006450-200105000-00005","volume":"49","author":"HL Levy","year":"2001","unstructured":"Levy HL, Guldberg P, Guttler F, Hanley WB, Matalon R, Rouse BM, Trefz F, Azen C, Allred EN, de la Cruz F, et al. Congenital heart disease in maternal phenylketonuria: Report from the maternal PKU collaborative study. Pediatr Res. 2001;49(5):636\u201342.","journal-title":"Pediatr Res"},{"issue":"5","key":"398_CR152","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10545-014-9716-5","volume":"37","author":"F Feillet","year":"2014","unstructured":"Feillet F, Muntau AC, Debray FG, Lotz-Havla AS, Puchwein-Schwepcke A, Fofou-Caillierez MB, van Spronsen F, Trefz FF. Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases. J Inherit Metab Dis. 2014;37(5):753\u201362.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"398_CR153","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ymgme.2014.02.016","volume":"112","author":"DK Grange","year":"2014","unstructured":"Grange DK, Hillman RE, Burton BK, Yano S, Vockley J, Fong CT, Hunt J, Mahoney JJ, Cohen-Pfeffer JL, Phenylketonuria Demographics O, et al. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: An interim report of the PKU MOMS sub-registry. Mol Genet Metab. 2014;112(1):9\u201316.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"398_CR154","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10545-012-9491-0","volume":"35","author":"R Teissier","year":"2012","unstructured":"Teissier R, Nowak E, Assoun M, Mention K, Cano A, Fouilhoux A, Feillet F, Ogier H, Oger E, de Parscau L, et al. Maternal phenylketonuria: Low phenylalaninemia might increase the risk of intra uterine growth retardation. J Inherit Metab Dis. 2012;35(6):993\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"398_CR155","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10545-010-9216-1","volume":"33","author":"FJ van Spronsen","year":"2010","unstructured":"van Spronsen FJ, de Groot MJ, Hoeksma M, Reijngoud DJ, van Rijn M. Large neutral amino acids in the treatment of PKU: From theory to practice. J Inherit Metab Dis. 2010;33(6):671\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"398_CR156","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jpeds.2012.10.015","volume":"162","author":"S Yano","year":"2013","unstructured":"Yano S, Moseley K, Azen C. Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: A new biomarker. J Pediatr. 2013;162(5):999\u20131003.","journal-title":"J Pediatr"},{"issue":"3","key":"398_CR157","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10545-012-9524-8","volume":"36","author":"KR Vogel","year":"2013","unstructured":"Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM. Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice. J Inherit Metab Dis. 2013;36(3):513\u201323.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"398_CR158","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1172\/JCI5017","volume":"103","author":"J Pietz","year":"1999","unstructured":"Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest. 1999;103(8):1169\u201378.","journal-title":"J Clin Invest"},{"issue":"2","key":"398_CR159","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/gim.2013.179","volume":"16","author":"RH Singh","year":"2014","unstructured":"Singh RH, Rohr F, Frazier D, Cunningham A, Mofidi S, Ogata B, Splett PL, Moseley K, Huntington K, Acosta PB, et al. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med. 2014;16(2):121\u201331.","journal-title":"Genet Med"},{"issue":"3","key":"398_CR160","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrd2540","volume":"7","author":"BK Burton","year":"2008","unstructured":"Burton BK, Kar S, Kirkpatrick P. Sapropterin. Nat Rev Drug Discov. 2008;7(3):199\u2013200.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"398_CR161","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13023-017-0600-x","volume":"12","author":"AC Muntau","year":"2017","unstructured":"Muntau AC, Burlina A, Eyskens F, Freisinger P, De Laet C, Leuzzi V, Rutsch F, Sivri HS, Vijay S, Bal MO, et al. Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: Results from the SPARK open-label, multicentre, randomized phase IIIb trial. Orphanet J Rare Dis. 2017;12(1):47.","journal-title":"Orphanet J Rare Dis"},{"key":"398_CR162","first-page":"231","volume":"4","author":"CO Harding","year":"2010","unstructured":"Harding CO. New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride. Biologics. 2010;4:231\u20136.","journal-title":"Biologics"},{"issue":"6","key":"398_CR163","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2125.2010.03643.x","volume":"69","author":"EA Dubois","year":"2010","unstructured":"Dubois EA, Cohen AF. Sapropterin. Br J Clin Pharmacol. 2010;69(6):576\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"398_CR164","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","volume":"77","author":"C Bernegger","year":"2002","unstructured":"Bernegger C, Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: A study of 1919 patients observed from 1988 to 2002. Mol Genet Metabol. 2002;77(4):304\u201313.","journal-title":"Mol Genet Metabol"},{"issue":"3","key":"398_CR165","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ymgme.2009.03.009","volume":"97","author":"I Karacic","year":"2009","unstructured":"Karacic I, Meili D, Sarnavka V, Heintz C, Thony B, Ramadza DP, Fumic K, Mardesic D, Baric I, Blau N. Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in croatian patients with phenylalanine hydroxylase (PAH) deficiency. Mol Genet Metab. 2009;97(3):165\u201371.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"398_CR166","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10528-018-9858-5","volume":"56","author":"K Klaassen","year":"2018","unstructured":"Klaassen K, Djordjevic M, Skakic A, Desviat LR, Pavlovic S, Perez B, Stojiljkovic M. Functional characterization of novel phenylalanine hydroxylase p.Gln226Lys mutation revealed Its non-responsiveness to tetrahydrobiopterin treatment in hepatoma cellular model. Biochem Genet. 2018;56(5):533\u201341.","journal-title":"Biochem Genet"},{"issue":"1","key":"398_CR167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","volume":"124","author":"J Thomas","year":"2018","unstructured":"Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, Harding CO, Bilder DA, Weng HH, Olbertz J, et al. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Mol Genet Metab. 2018;124(1):27\u201338.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"398_CR168","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymgme.2018.06.010","volume":"125","author":"R Zori","year":"2018","unstructured":"Zori R, Thomas JA, Shur N, Rizzo WB, Decker C, Rosen O, Li M, Schweighardt B, Larimore K, Longo N. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria. Mol Genet Metab. 2018;125(3):217\u201327.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"398_CR169","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41436-018-0403-z","volume":"21","author":"N Longo","year":"2019","unstructured":"Longo N, Dimmock D, Levy H, Viau K, Bausell H, Bilder DA, Burton B, Gross C, Northrup H, Rohr F, et al. Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genet Med. 2019;21(8):1851\u201367.","journal-title":"Genet Med"},{"key":"398_CR170","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","volume":"37","author":"S Gupta","year":"2018","unstructured":"Gupta S, Lau K, Harding CO, Shepherd G, Boyer R, Atkinson JP, Knight V, Olbertz J, Larimore K, Gu Z, et al. Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 2018;37:366\u201373.","journal-title":"EBioMedicine"},{"issue":"5","key":"398_CR171","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jama.285.5.545","volume":"285","author":"EH Kaji","year":"2001","unstructured":"Kaji EH, Leiden JM. Gene and stem cell therapies. JAMA. 2001;285(5):545\u201350.","journal-title":"JAMA"},{"issue":"9","key":"398_CR172","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJM199008303230904","volume":"323","author":"SA Rosenberg","year":"1990","unstructured":"Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, et al. Gene transfer into humans\u2013immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990;323(9):570\u20138.","journal-title":"N Engl J Med"},{"issue":"21","key":"398_CR173","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, et al. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2240\u20138.","journal-title":"N Engl J Med"},{"issue":"8","key":"398_CR174","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","volume":"34","author":"RO Bak","year":"2018","unstructured":"Bak RO, Gomez-Ospina N, Porteus MH. Gene editing on center stage. Trends Genet. 2018;34(8):600\u201311.","journal-title":"Trends Genet"},{"issue":"10","key":"398_CR175","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger L, Grisch-Chan HM, Lindsay H, Ringnalda F, Pogliano CB, Allegri G, Fingerhut R, Haberle J, Matos J, Robinson MD, et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat Med. 2018;24(10):1519\u201325.","journal-title":"Nat Med"},{"issue":"1","key":"398_CR176","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1038\/s41598-021-86663-8","volume":"11","author":"K Singh","year":"2021","unstructured":"Singh K, Cornell CS, Jackson R, Kabiri M, Phipps M, Desai M, Fogle R, Ying X, Anarat-Cappillino G, Geller S, et al. CRISPR\/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria. Sci Rep. 2021;11(1):7254.","journal-title":"Sci Rep"},{"key":"398_CR177","doi-asserted-by":"publisher","first-page":"35794","DOI":"10.1038\/srep35794","volume":"6","author":"Y Pan","year":"2016","unstructured":"Pan Y, Shen N, Jung-Klawitter S, Betzen C, Hoffmann GF, Hoheisel JD, Blau N. CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model. Sci Rep. 2016;6:35794.","journal-title":"Sci Rep"},{"issue":"4","key":"398_CR178","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","volume":"134","author":"A Shedlovsky","year":"1993","unstructured":"Shedlovsky A, McDonald JD, Symula D, Dove WF. Mouse models of human phenylketonuria. Genetics. 1993;134(4):1205\u201310.","journal-title":"Genetics"},{"issue":"10","key":"398_CR179","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/hmg\/ddq085","volume":"19","author":"SW Gersting","year":"2010","unstructured":"Gersting SW, Lagler FB, Eichinger A, Kemter KF, Danecka MK, Messing DD, Staudigl M, Domdey KA, Zsifkovits C, Fingerhut R, et al. Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo. Hum Mol Genet. 2010;19(10):2039\u201349.","journal-title":"Hum Mol Genet"},{"issue":"9586","key":"398_CR180","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","volume":"370","author":"HL Levy","year":"2007","unstructured":"Levy HL, Milanowski A, Chakrapani A, Cleary M, Lee P, Trefz FK, Whitley CB, Feillet F, Feigenbaum AS, Bebchuk JD, et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: A phase III randomised placebo-controlled study. Lancet. 2007;370(9586):504\u201310.","journal-title":"Lancet"},{"issue":"5","key":"398_CR181","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1073\/pnas.87.5.1965","volume":"87","author":"JD McDonald","year":"1990","unstructured":"McDonald JD, Bode VC, Dove WF, Shedlovsky A. Pahhph-5: A mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci U S A. 1990;87(5):1965\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"398_CR182","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol. 2018;36(9):857\u201364.","journal-title":"Nat Biotechnol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-022-00398-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T01:04:18Z","timestamp":1658192658000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-022-00398-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":182,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1186\/s40246-022-00398-9","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents of all the participants enrolled in this project (#43309030), which was approved by the Institutional Biomedical Ethics Committee of Umm Al-Qura University. The study was performed by the declaration of the National Committee of Biomedical Ethics at King Abdulaziz City for Sciences and Technology (KACST) (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of all study participants to publish the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}